Suchergebnisse - "Blanchard, Lucas"

PubPharm (9)

1

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

enthalten in: Cancer immunology research | 2024

von Knorr, D. | Blanchard, L. | Leidner, R. | +14

UpdateOf: bioRxiv. 2023 Jan 20;:. - PMID 36711504

2

A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

enthalten in: Science (New York, N.Y.) | 2023

von Fidelle, M. | Rauber, C. | Alves Costa Silva, C. | +63

CommentIn: Trends Immunol. 2023 Aug;44(8):568-570. - PMID 37451906

3

Tumor-associated HEVs mediate lymphocyte entry into tumors during cancer immunotherapy

enthalten in: Medecine sciences : M/S | 2022

von Blanchard, L. | Girard, J.

4

Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models

enthalten in: STAR protocols | 2022

von Blanchard, L. | Vina, E. | Asrir, A. | +12

5

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

enthalten in: Cancer cell | 2022

von Asrir, A. | Tardiveau, C. | Coudert, J. | +16

CommentIn: Cancer Cell. 2022 Mar 14;40(3):243-245. - PMID 35176235

6

High endothelial venules (HEVs) in immunity, inflammation and cancer

enthalten in: Angiogenesis | 2021

von Blanchard, L. | Girard, J.

7

High endothelial venules (HEVs) in immunity, inflammation and cancer

enthalten in: Angiogenesis | 2021

von Blanchard, L. | Girard, J.

8

High endothelial venules (HEVs) in immunity, inflammation and cancer

enthalten in: Angiogenesis | 2021

von Blanchard, L. | Girard, J.

9

High endothelial venules (HEVs) in immunity, inflammation and cancer

enthalten in: Angiogenesis | 2021

von Blanchard, L. | Girard, J.

1
[1]